Trial Scout

A Study of Oral VT-1161 for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

Health System

OBGYN Associates of WNY

ClinicalTrials.gov Identifier: NCT03562156
Recruitment Status: Recruiting
First Posted: 6/19/2018 12:00:00 AM
Last Update Posted: 4/17/2019 12:00:00 AM

Study Description

Eligibility Criteria

Additional Contacts

Brief Summary

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VT-1161 Oral Capsules in the Treatment of Subjects With Recurrent Vulvovaginal Candidiasis

Condition or Disease

Candidiasis
Candidiasis, Vulvovaginal

Intervention/Treatment

Drug: VT-1161 / VT-1161 150mg capsule

Phase

Phase 3

Detailed Description

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

Go to ClinicalTrials.gov >